Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Little

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Plos One|April 6, 2012
Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patientsLaura Breda, Carla Casu, Sara Gardenghi, et al.
Blood Advances|September 27, 2018
Increased acute care utilization in a prospective cohort of adults with sickle cell diseaseSophie Lanzkron, Jane Little, Joshua Field, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2019
A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid LeukemiaAnjali S Advani, Brenda Cooper, Valeria Visconte, et al.
Annals of Internal Medicine|July 5, 2021
Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort StudySophie Lanzkron, Jane Little, Hang Wang, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.
The Lancet. Haematology|March 30, 2024
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trialMark T Gladwin, Victor R Gordeuk, Payal C Desai, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Plos One|April 6, 2012
Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patientsLaura Breda, Carla Casu, Sara Gardenghi, et al.
Blood Advances|September 27, 2018
Increased acute care utilization in a prospective cohort of adults with sickle cell diseaseSophie Lanzkron, Jane Little, Joshua Field, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2019
A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid LeukemiaAnjali S Advani, Brenda Cooper, Valeria Visconte, et al.
Annals of Internal Medicine|July 5, 2021
Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort StudySophie Lanzkron, Jane Little, Hang Wang, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.
The Lancet. Haematology|March 30, 2024
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trialMark T Gladwin, Victor R Gordeuk, Payal C Desai, et al.
Pageof 3